Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?

Published

on

Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Shares of pharma companies rallied up to 7% on Wednesday as strong earnings, a weakening rupee, and other supportive factors lifted investor sentiment, even as benchmark indices Sensex and Nifty traded in the red.

After opening lower, the Nifty Pharma index reversed losses and climbed nearly 1% to cross the 25,000 mark. The sectoral index also touched a fresh 52-week high of 25,043 during early trade before trimming some gains.

The Indian currency fell to 96.96 per dollar, breaching its all-time ‌low of 96.6150 ⁠hit ⁠in the previous session. The currency is down 6% since the Iran war began in late February. A falling rupee is typically considered a positive for the export-heavy pharma sector.

Top pharma gainers today

Zydus Lifesciences shares were the top gainers on the index, jumping over 7% to hit a fresh 52-week high of Rs 1,091 apiece on NSE after the pharma company reported a 9% year-on-year (YoY) rise in consolidated net profit to Rs 1,272.5 crore for the January-March quarter of FY26. Revenue from operations, meanwhile, rose more than 16% YoY to Rs 7,587 crore during the quarter under review.Along with the Q4 results, Zydus Lifesciences announced its biggest-ever share buyback worth Rs 1,100 crore via the tender route at a buyback price of Rs 1,150 per share, offering nearly a 13% premium over the stock’s previous closing price. Its board has also recommended a final dividend of Re 1 per share (100%) on a face value of Re 1 each, subject to shareholders’ approval at the company’s Annual General Meeting scheduled for August 11.

Advertisement

Mankind Pharma shares followed, surging over 3%. This comes after the company reported a 32% YoY rise in consolidated net profit to Rs 554 crore for the fourth quarter of the financial year 2026, from Rs 421 crore in the corresponding quarter of the previous financial year. The firm’s revenue from operations rose 12% YoY to Rs 3,443 crore during the quarter under review.
Laurus Labs, Aurobindo Pharma, and Biocon shares gained around 1% each, while those of Lupin, Sun Pharma, Cipla, Torrent Pharma, and Divi’s Laboratories were trading in the green with marginal gains, as seen at 11 am. Bucking the trend, however, Ajanta Pharma, Piramal Pharma, Gland Pharma, Dr Reddy’s Labs, Abbot India, Glenmark, Alkem Labs, and IPCA Labs shares fell up to 1%.

What lies ahead?

Nifty Pharma’s technical structure remains constructive after the index touched a fresh 52-week high today, according to Harshal Dasani, Business Head at INVasset PMS, who said that this is significant as it has come at a time when the broader market is still dealing with global risk-off pressure, currency weakness, and uneven earnings delivery. The relative strength in pharma counters suggests capital is rotating into sectors with better earnings visibility, not merely chasing momentum, he added.“The index has been forming a clear higher-high, higher-low pattern, and the latest breakout keeps the medium-term trend in favour of buyers as long as it holds above the recent breakout zone. The immediate support now sits around 24,700 to 24,800, while a stronger cushion is visible near 24,400. A close below that band would weaken the breakout and indicate profit-booking rather than trend continuation,” according to Dasani.

The risk-reward remains favourable, but the entry point is no longer fresh after a sharp move, the analyst said. “The cleaner setup would come on controlled pullbacks rather than vertical rallies. The key confirmation from here is breadth. If participation remains broad across large pharma, domestic formulations and speciality businesses, the breakout could extend. If leadership narrows, the index may pause before attempting the next leg,” he added.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Three sons of Iran’s slain leader Khamenei appear at funeral, not his successor

Published

on

Three sons of Iran’s slain leader Khamenei appear at funeral, not his successor


Three sons of Iran’s slain leader Khamenei appear at funeral, not his successor

Continue Reading

Business

China Is Devastating the Last Stronghold of German Industry

Published

on

China Is Devastating the Last Stronghold of German Industry

FRANKFURT—For decades, thousands of niche, world-class manufacturers that form the backbone of the German economy relied on an unassailable moat: unmatched quality. Now that moat is drying up.

The Mittelstand—a broad tier of midsize manufacturers, mainly specialized in capital and intermediate goods and reliant on exports—once thrived by making machines for factories everywhere. But China is now closing the quality gap and offering prices as low as half those of their European rivals.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Bread Financial: A High-Quality Lender Trading At A Discount

Published

on

Bread Financial: A High-Quality Lender Trading At A Discount

Bread Financial: A High-Quality Lender Trading At A Discount

Continue Reading

Business

EV battery durability exceeds expectations as replacement fears persist

Published

on


EV battery durability exceeds expectations as replacement fears persist

Continue Reading

Business

Artisan Partners Asset Management: Limited Downside

Published

on

Whale's Insight: A Macro-Driven Market With No Safe Haven, And No End To Volatility

Artisan Partners Asset Management: Limited Downside

Continue Reading

Business

Equity mutual funds delivered up to 8% return last week; international funds led. Check top 10 performers

Published

on

Equity mutual funds delivered up to 8% return last week; international funds led. Check top 10 performers

Equity mutual funds delivered up to 8% return last week; international funds led. Check top 10 performers

Continue Reading

Business

Taiwan military resumes ’anti-communist’ classes for graduates, citing Chinese threat

Published

on

Taiwan military resumes ’anti-communist’ classes for graduates, citing Chinese threat


Taiwan military resumes ’anti-communist’ classes for graduates, citing Chinese threat

Continue Reading

Business

China seeks closer business ties with Europe as Wang meets Wallenberg

Published

on


China seeks closer business ties with Europe as Wang meets Wallenberg

Continue Reading

Business

Investors looking for shelter from AI storm are turning to India

Published

on

Investors looking for shelter from AI storm are turning to India
After losing out big on the global AI rally, Indian equities are regaining the attention of investors seeking to weather the latest market turbulence.

With the artificial intelligence frenzy roiling benchmark gauges from Asia to the US, the NSE Nifty 50 Index is becoming a safe haven of sorts for global investors. In the first half of the year, it moved 1% or more on just about one-third of the days — less than the MSCI Emerging Markets Index and barely more than the S&P 500 Index.

India’s lack of AI plays has been a hurdle most of the year as investors turned to markets like South Korea and Taiwan that delivered stellar returns. But with concerns mounting over the sustainability of that trade, interest in India is slowly coming back. In June, the Nifty 50 outperformed the MSCI Emerging Markets Index by the most since November, while foreign outflows were the smallest in four months.

“India’s calm comes down to one thing: It sits outside the AI trade,” said Maxence Visseau, chief investment officer of Arkevium Capital in Dubai. His firm is neutral on the market and uses it as a diversifier, he said. “India works as an AI hedge inside the EM complex.”

Advertisement
Image 1ETMarkets.com

Indian equities remain some of the world’s worst performers this year, but the tide is starting to turn as the rupee stabilizes after hitting a record low and oil gains that tanked shares of refiners and airlines recede on easing tensions in the Middle East. That’s reduced inflation concerns and brightened prospects for India’s economic growth, according to a government report at the end of June.


At the same time, market players are getting more upbeat about the upcoming earnings season, which Tata Consultancy Services Ltd. kicks off on Thursday.
“The fall in commodity prices has altered the macro outlook for India almost overnight,” said Sandip Sabharwal, founder of research house Asksandipsabharwal.com in Mumbai. “Lower commodity prices, improving capital flows and stable interest rates create an environment where earnings upgrades are likely to exceed downgrades over the coming quarters.”In a note to clients, Morgan Stanley analysts including Ridham Desai wrote last month that India has become a “much larger macro asset class.” The less volatile inflation data in recent years support equity valuations and turn the market into one of defensive growth that can withstand global shocks better than it used to, they said. Over the past decade, the Nifty 50 almost tripled, delivering annual gains of more than 10% on six separate years.

The benchmark index logged 38 sessions with moves of 1% or more in either direction in the first six months of 2026, compared with 59 for MSCI’s emerging-market and Asian gauges and 32 for the S&P 500. South Korea’s Kospi index was off the charts, with 79 days of fluctuations of at least 1% — or two-thirds of the days in 2026.

Image 2ETMarkets.com

Meanwhile, the India NSE Volatility Index dropped for a third straight month in June, falling below its one-year average and reaching its lowest level since February on Friday. That’s a far cry from April, when the gauge of option prices was at a one-year high relative to the Cboe Volatility Index, shortly after the Nifty 50 tanked to a low.

Kruti Shah, a quantitative analyst at Equirus Securities, sees a “bullish undertone” in the Nifty 50 and favors call spreads to bet on more gains, adding that the upcoming earnings season may offer some positive surprises.

“India was held back earlier this year by higher energy prices, elevated valuations and limited exposure to the AI trade,” said Ben Powell, chief investment strategist for the Middle East and Asia Pacific at BlackRock Investment Institute. “As those pressures have eased, investors may look beyond AI-heavy markets. That could put India back on investors’ radar as a differentiated opportunity within emerging markets.”

Advertisement
Continue Reading

Business

Uber pauses Europe food delivery expansion as it pursues Delivery Hero deal, FT reports

Published

on

Uber pauses Europe food delivery expansion as it pursues Delivery Hero deal, FT reports


Uber pauses Europe food delivery expansion as it pursues Delivery Hero deal, FT reports

Continue Reading

Trending

Copyright © 2025